Annual EBITDA:
$1.08B+$255.98M(+31.24%)Summary
- As of today, GMAB annual EBITDA is $1.08 billion, with the most recent change of +$255.98 million (+31.24%) on December 31, 2024.
- During the last 3 years, GMAB annual EBITDA has risen by +$556.10 million (+107.07%).
- GMAB annual EBITDA is now at all-time high.
Performance
GMAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$380.81M+$176.67M(+86.54%)Summary
- As of today, GMAB quarterly EBITDA is $380.81 million, with the most recent change of +$176.67 million (+86.54%) on June 1, 2025.
- GMAB quarterly EBITDA is now -42.75% below its all-time high of $665.22 million, reached on June 30, 2020.
Performance
GMAB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.24B+$380.81M(+44.14%)Summary
- As of today, GMAB TTM EBITDA is $1.24 billion, with the most recent change of +$380.81 million (+44.14%) on June 1, 2025.
- GMAB TTM EBITDA is now at all-time high.
Performance
GMAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GMAB EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +31.2% | - | - |
3Y3 Years | +107.1% | - | - |
5Y5 Years | +158.3% | -42.8% | +9.4% |
GMAB EBITDA Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +107.1% | at high | +86.5% | at high | +381.2% |
5Y | 5-Year | at high | +158.3% | at high | +179.4% | at high | +381.2% |
All-Time | All-Time | at high | +883.4% | -42.8% | +743.1% | at high | +911.6% |
GMAB EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $380.81M(+86.5%) | $1.24B(+44.1%) |
Mar 2025 | - | $204.14M(-38.2%) | $862.77M(+31.0%) |
Dec 2024 | $1.08B(+31.2%) | $330.27M(+0.6%) | $658.63M(+14.1%) |
Sep 2024 | - | $328.36M(+32.0%) | $577.08M(+13.8%) |
Dec 2023 | $819.51M(-12.0%) | $248.71M(-3.8%) | $507.15M(+96.2%) |
Sep 2023 | - | $258.44M(+79.7%) | $258.44M(-73.0%) |
Dec 2022 | $931.68M(+79.4%) | - | - |
Dec 2021 | $519.39M(-48.2%) | - | - |
Dec 2020 | $1.00B(+140.9%) | $143.84M(+5.5%) | $956.83M(-15.8%) |
Sep 2020 | - | $136.27M(-79.5%) | $1.14B(+7.9%) |
Jun 2020 | - | $665.22M(+5684.0%) | $1.05B(+157.0%) |
Mar 2020 | - | $11.50M(-96.4%) | $410.01M(+3.6%) |
Dec 2019 | $416.30M(+79.2%) | $323.55M(+507.3%) | $395.61M(+449.0%) |
Sep 2019 | - | $53.28M(+145.8%) | $72.06M(+283.6%) |
Jun 2019 | - | $21.68M(+848.8%) | $18.78M(+748.8%) |
Mar 2019 | - | -$2.90M(-253.0%) | -$2.90M(+84.8%) |
Dec 2018 | $232.36M(+8.4%) | - | - |
Dec 2017 | $214.40M(+31.9%) | - | - |
Dec 2016 | $162.51M(+86.5%) | - | - |
Dec 2015 | $87.12M(+76.4%) | - | - |
Dec 2014 | $49.38M(+242.8%) | - | - |
Dec 2013 | $14.40M(+182.2%) | - | - |
Dec 2012 | -$17.53M(+59.8%) | -$820.10K(+78.4%) | -$19.04M(+34.3%) |
Sep 2012 | - | -$3.80M(+45.8%) | -$28.96M(+18.2%) |
Jun 2012 | - | -$7.01M(+5.4%) | -$35.42M(+12.5%) |
Mar 2012 | - | -$7.41M(+31.0%) | -$40.47M(+7.6%) |
Dec 2011 | -$43.64M(>-9900.0%) | -$10.74M(-4.7%) | -$43.80M(+8.7%) |
Sep 2011 | - | -$10.26M(+15.0%) | -$47.99M(-548.8%) |
Jun 2011 | - | -$12.06M(-12.3%) | -$7.40M(+27.8%) |
Mar 2011 | - | -$10.74M(+28.0%) | -$10.25M(+59.7%) |
Dec 2010 | -$378.00K(+99.5%) | -$14.93M(-149.2%) | -$25.43M(-6904.6%) |
Sep 2010 | - | $30.34M(+303.4%) | -$363.00K(+99.5%) |
Jun 2010 | - | -$14.91M(+42.5%) | -$67.14M(+27.4%) |
Mar 2010 | - | -$25.92M(-355.8%) | -$92.49M(-13.8%) |
Dec 2009 | -$74.12M(+46.0%) | $10.14M(+127.8%) | -$81.29M(+46.0%) |
Sep 2009 | - | -$36.44M(+9.5%) | -$150.63M(-29.4%) |
Jun 2009 | - | -$40.27M(-173.7%) | -$116.41M(+9.8%) |
Mar 2009 | - | -$14.71M | -$129.00M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2008 | -$137.28M(-75.5%) | - | - |
Dec 2008 | - | -$59.21M(-2571.8%) | -$153.23M(-29.4%) |
Sep 2008 | - | -$2.22M(+95.8%) | -$118.43M(+21.5%) |
Jun 2008 | - | -$52.86M(-35.8%) | -$150.94M(-51.4%) |
Mar 2008 | - | -$38.94M(-59.5%) | -$99.72M(-26.5%) |
Dec 2007 | -$78.24M(-1.4%) | - | - |
Dec 2007 | - | -$24.41M(+29.7%) | -$78.86M(+1.1%) |
Sep 2007 | - | -$34.72M(-2011.0%) | -$79.76M(-17.9%) |
Jun 2007 | - | -$1.64M(+90.9%) | -$67.63M(+16.5%) |
Mar 2007 | - | -$18.08M(+28.6%) | -$81.03M(-4.6%) |
Dec 2006 | -$77.13M(-17.1%) | - | - |
Dec 2006 | - | -$25.31M(-12.1%) | -$77.49M(-13.9%) |
Sep 2006 | - | -$22.59M(-50.1%) | -$68.05M(-11.9%) |
Jun 2006 | - | -$15.05M(-3.6%) | -$60.79M(+3.8%) |
Mar 2006 | - | -$14.53M(+8.5%) | -$63.20M(+4.1%) |
Dec 2005 | -$65.89M(+0.7%) | - | - |
Dec 2005 | - | -$15.88M(-3.5%) | -$65.89M(+6.2%) |
Sep 2005 | - | -$15.33M(+12.2%) | -$70.24M(+0.3%) |
Jun 2005 | - | -$17.46M(-1.4%) | -$70.42M(-1.5%) |
Mar 2005 | - | -$17.22M(+14.9%) | -$69.41M(-6.1%) |
Dec 2004 | -$66.38M(-55.2%) | - | - |
Dec 2004 | - | -$20.23M(-30.4%) | -$65.45M(-4.7%) |
Sep 2004 | - | -$15.51M(+5.7%) | -$62.51M(-2.6%) |
Jun 2004 | - | -$16.45M(-24.1%) | -$60.95M(-36.9%) |
Mar 2004 | - | -$13.26M(+23.3%) | -$44.53M(-3.8%) |
Dec 2003 | -$42.77M(+23.2%) | - | - |
Dec 2003 | - | -$17.29M(-23.9%) | -$42.92M(+8.4%) |
Sep 2003 | - | -$13.95M(>-9900.0%) | -$46.86M(-2.1%) |
Jun 2003 | - | -$24.90K(+99.8%) | -$45.91M(+19.0%) |
Mar 2003 | - | -$11.64M(+45.2%) | -$56.66M(-0.7%) |
Dec 2002 | -$55.72M(-117.8%) | - | - |
Dec 2002 | - | -$21.24M(-63.3%) | -$56.24M(-60.7%) |
Sep 2002 | - | -$13.00M(-20.7%) | -$35.00M(-59.1%) |
Jun 2002 | - | -$10.78M(+4.0%) | -$22.00M(-96.0%) |
Mar 2002 | - | -$11.22M(-239.3%) | -$11.22M(-239.3%) |
Dec 2001 | -$25.59M(-257.7%) | - | - |
Mar 2001 | - | -$3.31M | -$3.31M |
Dec 2000 | -$7.15M(-349.7%) | - | - |
Dec 1999 | -$1.59M | - | - |
FAQ
- What is Genmab A/S annual EBITDA?
- What is the all-time high annual EBITDA for Genmab A/S?
- What is Genmab A/S annual EBITDA year-on-year change?
- What is Genmab A/S quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Genmab A/S?
- What is Genmab A/S TTM EBITDA?
- What is the all-time high TTM EBITDA for Genmab A/S?
What is Genmab A/S annual EBITDA?
The current annual EBITDA of GMAB is $1.08B
What is the all-time high annual EBITDA for Genmab A/S?
Genmab A/S all-time high annual EBITDA is $1.08B
What is Genmab A/S annual EBITDA year-on-year change?
Over the past year, GMAB annual EBITDA has changed by +$255.98M (+31.24%)
What is Genmab A/S quarterly EBITDA?
The current quarterly EBITDA of GMAB is $380.81M
What is the all-time high quarterly EBITDA for Genmab A/S?
Genmab A/S all-time high quarterly EBITDA is $665.22M
What is Genmab A/S TTM EBITDA?
The current TTM EBITDA of GMAB is $1.24B
What is the all-time high TTM EBITDA for Genmab A/S?
Genmab A/S all-time high TTM EBITDA is $1.24B